跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Approved
STANDARD
VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Seacross Pharma (Europe) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 16, 2024
Approval ID
d083e489b0dd88e3
Company
Seacross Pharma (Europe) Limited
Type
Standard
Approval Details
Approval Id
d083e489b0dd88e3
Drug Cima Aemps Name
VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Register Number
90020
Holder Company Name
Seacross Pharma (Europe) Limited
Marketing Company Name
Pharmavic Iberica S.L.
Authorization Date
2024-12-16
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
200 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Seacross Pharma (Europe) Limited
Active Ingredients
VORICONAZOL
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 16, 2024
Approval ID
d083e489b0dd88e3
Type
Standard
Back to CIMA-AEMPS Approvals